14 February 2025

Semaglutide Shows Promise in Reducing Alcohol and Cigarette Consumption

A recent study suggests that semaglutide, a medication commonly prescribed for diabetes and obesity, may also help reduce alcohol intake. Researchers found that weekly injections of semaglutide lowered alcohol cravings, decreased consumption, and reduced the number of heavy drinking days in individuals with alcohol use disorder.

Participants receiving the drug drank less in a controlled lab setting and reported fewer cravings compared to those given a placebo. Notably, semaglutide appeared to have a stronger effect on drinking behavior than existing FDA-approved treatments for alcohol use disorder.

Additionally, a small subgroup of smokers experienced a reduction in cigarette consumption while taking semaglutide. These findings highlight the drug’s potential role in addressing addiction, though further research is needed to determine its long-term effectiveness and ideal dosing.